一般演題（ポスター）61B TIP 2

[P61B-3] Valemetostat（Vale）and Dato-DXd in 2L+, Advanced, Unresectable, or Metastatic Non-Squamous NSCLC

^○Noboru Yamamoto¹, Alexander I. Spira², Avani Mohapatra³, Jacob Sands⁴ (1.National Cancer Center Hospital, Tokyo, Japan, 2.Virginia Cancer Specialists, Fairfax, VA, US, 3.Daiichi Sankyo Inc., Basking Ridge, NJ, US, 4.Dana-Farber Cancer Institute, Boston, MA, US)